Company intelligence / Profile preview

Focus & Fusion Healthcare

Hangzhou, Zhejiang, Chinafocus-fusion.com ↗

Ownership: Private
Development stage: Commercial

Overview

Focus & Fusion Healthcare has commercialized a portfolio of advanced ultrasound systems, including the recent global launch of the Cygnus automated breast ultrasound system in 2024. The company’s products are recognized for high performance and reliability, with over 100 patents registered and international design awards received. They have established R&D centers globally and maintain a strong focus on innovation in clinical diagnostics.

Therapeutic areas: OtherOncology
Modalities: Device (Ultrasound system)Software (Imaging algorithms)Hardware (Transducers)
Industry: Medical Imaging

Partnerships

Engaged in partnerships across more than 50 countries as of recent years; specific partners not listed.

Beyond the preview

Go deeper on Focus & Fusion Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Focus & Fusion Healthcare.

Explore the full profile